Stockscreener 앱 받기
53.76
3.90%
2.02
시간 외 거래:
53.76
Tarsus Pharmaceuticals Inc 주식(TARS)의 최신 뉴스
Tarsus to Participate in Upcoming Investor Conferences - GlobeNewswire
Exclusive Access: Tarsus Pharma's Double-Header at Elite Healthcare Investment Forums - StockTitan
Tarsus to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.
How To Trade (TARS) - Stock Traders Daily
Tarsus Pharmaceuticals (NASDAQ:TARS) Given New $62.00 Price Target at Barclays - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Trading Up 9% After Analyst Upgrade - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Trading 9% Higher After Analyst Upgrade - MarketBeat
A Glimpse Into The Expert Outlook On Tarsus Pharmaceuticals Through 4 Analysts - Benzinga
Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target Raised to $62.00 at Barclays - MarketBeat
Oppenheimer lifts Tarsus stock target, impressed by execution and ocular rosacea potential - MSN
Tarsus Pharmaceuticals Inc (NASDAQ: TARS): An Enticing Stock To Watch - Stocks Register
Midday Stock Roundup: Virgin Galactic down 2.3% and 87% YoY - Orange County Business Journal
Tarsus: Promising Investment, But Timing Is The Key (NASDAQ:TARS) - Seeking Alpha
Oppenheimer Increases Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $72.00 - MarketBeat
First Week of TARS March 21st Options Trading - Nasdaq
Tarsus PharmaceuticalEye Care Therapeutics - MSN
Is Tarsus Pharmaceuticals (TARS) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Insider Monkey
Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks - Insider Monkey
Tarsus Pharmaceuticals reshuffles board, appoints new committee chair By Investing.com - Investing.com South Africa
Tarsus Pharmaceuticals reshuffles board, appoints new committee chair - MSN
Grant GrossMendelsohn LLC Sells 14,331 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives $54.20 Average Target Price from Analysts - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Publishes Corporate Presentation – Enhances Stakeholder InsightOn January 13, 2025, Tarsus Pharmaceuticals, Inc. shared its corporate presentation on its website’s Investor & News section, as detailed in the lates - Defense World
Tarsus Pharmaceuticals, Inc Announces Board and Committee Changes -January 17, 2025 at 05:09 pm EST - Marketscreener.com
Assenagon Asset Management S.A. Buys 5,565 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Down -9.11% in 4 Weeks, Here's Why Tarsus Pharmaceuticals (TARS) Looks Ripe for a Turnaround - MSN
Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Down 6.3%Time to Sell? - MarketBeat
Tarsus Pharmaceuticals is Now Oversold (TARS) - Nasdaq
Tarsus CEO Bobby Azamian: Clearing Crusty Eyelids with Xdemvy - Orange County Business Journal
Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap DownTime to Sell? - MarketBeat
Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY - WICZ
Tarsus Provides 2025 Update: Accelerating the Launch of - GlobeNewswire
Tarsus' XDEMVY Eye Treatment Hits $113M Sales, Plans New Rosacea Drug Development - StockTitan
Analysts Expect Breakeven For Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Before Long - Simply Wall St
JPMorgan Chase & Co. Has $14.48 Million Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
JPMorgan Chase & Co. Buys 420,057 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength? - Yahoo Finance
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Bought by Franklin Resources Inc. - Defense World
Tarsus Pharmaceuticals stock soars to 52-week high of $56.84 By Investing.com - Investing.com Australia
Tarsus Pharmaceuticals (NASDAQ:TARS) Sets New 12-Month HighHere's What Happened - MarketBeat
Tarsus Pharmaceuticals stock soars to 52-week high of $56.84 - Investing.com
How Tarsus Pharmaceuticals' Unique Inspiration Is Driving A Triple-Digit Run - MSN
Geode Capital Management LLC Increases Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Geode Capital Management LLC Purchases 62,555 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
3.95%
2.39%
자본화:
|
볼륨(24시간):